| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.642 | 0.005 | 0.642 | Superoxide dismutase inhibitor | |||
| 0.536 | 0.007 | 0.536 | Peroxidase inhibitor | |||
| 0.538 | 0.019 | 0.538 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.324 0.182 CID_154699830 | ||
| 0.5 | 0.008 | 0.5 | Anesthetic general | 0.158 0.105 CID_154699830 | ||
| 0.475 | 0.036 | 0.475 | Aldehyde oxidase inhibitor | |||
| 0.469 | 0.043 | 0.469 | 5 Hydroxytryptamine release inhibitor | 0.299 0.166 CID_154699830 | ||
| 0.426 | 0.01 | 0.426 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.407 | 0.026 | 0.407 | Tumour necrosis factor alpha release inhibitor | 0.209 0.101 CID_154699830 | ||
| 0.431 | 0.06 | 0.448 | Histamine release inhibitor | 0.448 0.051 CID_154699830 | CID_154699830 | |
| 0.422 | 0.052 | 0.422 | GABA C receptor rho-3 antagonist | |||
| 0.373 | 0.004 | 0.373 | Alcohol oxidase inhibitor | 0.064 0.032 CID_154699830 | ||
| 0.414 | 0.047 | 0.561 | Cholesterol antagonist | 0.561 0.024 CID_154699830 | CID_154699830 | |
| 0.404 | 0.045 | 0.404 | 5 Hydroxytryptamine release stimulant | |||
| 0.352 | 0.01 | 0.352 | Gastrin inhibitor | 0.213 0.13 CID_154699830 | ||
| 0.393 | 0.056 | 0.633 | Angiogenesis inhibitor | 0.633 0.014 CID_154699830 | CID_154699830 | |
| 0.318 | 0.017 | 0.318 | Phospholipase C inhibitor | 0.23 0.03 CID_154699830 | ||
| 0.366 | 0.074 | 0.366 | Toll-Like receptor 7 agonist | |||
| 0.365 | 0.075 | 0.365 | Toll-Like receptor agonist | |||
| 0.292 | 0.013 | 0.292 | Nitric-oxide synthase stimulant | 0.176 0.138 CID_154699830 | ||
| 0.276 | 0.018 | 0.276 | Cytokine production inhibitor | |||
| 0.284 | 0.028 | 0.284 | Neuropeptide Y2 antagonist | |||
| 0.266 | 0.02 | 0.266 | Interleukin 6 antagonist | |||
| 0.319 | 0.074 | 0.319 | Calcium channel activator | |||
| 0.252 | 0.009 | 0.252 | Histidine decarboxylase inhibitor | |||
| 0.261 | 0.028 | 0.261 | Insulin sensitizer | 0.154 0.128 CID_154699830 | ||
| 0.318 | 0.086 | 0.318 | Transcription factor NF kappa B inhibitor | 0.254 0.125 CID_154699830 | ||
| 0.326 | 0.099 | 0.326 | Calpain 2 inhibitor | |||
| 0.273 | 0.049 | 0.273 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.258 | 0.034 | 0.258 | LIM domain kinase 1 inhibitor | |||
| 0.281 | 0.065 | 0.361 | DNA damaging | 0.361 0.038 CID_154699830 | CID_154699830 | |
| 0.237 | 0.023 | 0.237 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.287 | 0.078 | 0.287 | Lipoxygenase inhibitor | |||
| 0.214 | 0.005 | 0.214 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.213 | 0.013 | 0.213 | Catalase inhibitor | |||
| 0.205 | 0.008 | 0.205 | Keratolytic | |||
| 0.227 | 0.035 | 0.227 | Diuretic | 0.159 0.07 CID_154699830 | ||
| 0.213 | 0.021 | 0.213 | MAP kinase kinase 5 inhibitor | |||
| 0.201 | 0.01 | 0.201 | Urease inhibitor | |||
| 0.206 | 0.016 | 0.206 | Neuropeptide Y1 antagonist | |||
| 0.2 | 0.011 | 0.2 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.216 | 0.037 | 0.216 | Succinate dehydrogenase inhibitor | |||
| 0.237 | 0.06 | 0.237 | MAP kinase kinase 2 inhibitor | |||
| 0.227 | 0.05 | 0.227 | Focal adhesion kinase 2 inhibitor | |||
| 0.179 | 0.018 | 0.179 | Adenylate kinase inhibitor | 0.148 0.027 CID_154699830 | ||
| 0.195 | 0.041 | 0.195 | ATPase inhibitor | |||
| 0.179 | 0.029 | 0.179 | 5-Lipoxygenase inhibitor | |||
| 0.222 | 0.073 | 0.222 | Interleukin antagonist | |||
| 0.167 | 0.02 | 0.167 | Gastric antisecretory | |||
| 0.22 | 0.075 | 0.22 | MAP kinase kinase 3 inhibitor | |||
| 0.228 | 0.085 | 0.545 | DNA synthesis inhibitor | 0.545 0.01 CID_154699830 | CID_154699830 | |
| 0.23 | 0.088 | 0.23 | Aryl hydrocarbon receptor agonist | |||
| 0.168 | 0.027 | 0.168 | 5 Hydroxytryptamine 3A agonist | |||
| 0.158 | 0.018 | 0.158 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.216 | 0.078 | 0.216 | RNA-directed DNA polymerase inhibitor | 0.181 0.13 CID_154699830 | ||
| 0.179 | 0.041 | 0.261 | Alpha-N-acetylglucosaminidase inhibitor | 0.261 0.021 CID_154699830 | CID_154699830 | |
| 0.315 | 0.178 | 0.315 | Caspase 9 stimulant | |||
| 0.234 | 0.097 | 0.234 | Transcription factor STAT3 inhibitor | |||
| 0.231 | 0.094 | 0.231 | Interleukin agonist | 0.171 0.148 CID_154699830 | ||
| 0.159 | 0.026 | 0.299 | UDP-glucose 4-epimerase inhibitor | 0.299 0.01 CID_154699830 | CID_154699830 | |
| 0.148 | 0.017 | 0.148 | I kappa B kinase inhibitor | |||
| 0.257 | 0.127 | 0.281 | Vasodilator, coronary | 0.281 0.104 CID_154699830 | CID_154699830 | |
| 0.142 | 0.012 | 0.142 | Histamine H2 receptor antagonist | |||
| 0.188 | 0.061 | 0.188 | Tumour necrosis factor antagonist | |||
| 0.169 | 0.044 | 0.169 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.168 | 0.045 | 0.168 | M17 leucyl aminopeptidase inhibitor | 0.112 0.086 CID_154699830 | ||
| 0.177 | 0.056 | 0.177 | Phospholipase A2 inhibitor | |||
| 0.151 | 0.03 | 0.151 | Carbonic anhydrase XV inhibitor | |||
| 0.132 | 0.015 | 0.132 | Epoxide hydrolase inhibitor | 0.096 0.028 CID_154699830 | ||
| 0.15 | 0.033 | 0.15 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.133 | 0.016 | 0.133 | Phosphodiesterase 6D inhibitor | |||
| 0.132 | 0.017 | 0.132 | Check point kinase 1 inhibitor | |||
| 0.138 | 0.024 | 0.173 | Triose-phosphate isomerase inhibitor | 0.173 0.015 CID_154699830 | CID_154699830 | |
| 0.284 | 0.171 | 0.284 | Calcium channel L-type activator | |||
| 0.12 | 0.009 | 0.12 | NMDA receptor glycine site agonist | |||
| 0.191 | 0.08 | 0.191 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.175 0.099 CID_154699830 | ||
| 0.192 | 0.082 | 0.192 | Histone acetyltransferase inhibitor | |||
| 0.143 | 0.036 | 0.143 | Mucolytic | 0.098 0.08 CID_154699830 | ||
| 0.146 | 0.039 | 0.146 | Ferrochelatase inhibitor | |||
| 0.115 | 0.01 | 0.115 | Potassium channel (ATP-sensitive) blocker | |||
| 0.121 | 0.016 | 0.121 | Leukotriene synthesis inhibitor | |||
| 0.142 | 0.041 | 0.142 | Aminopeptidase B inhibitor | |||
| 0.162 | 0.063 | 0.162 | Insulin secretagoues | 0.157 0.068 CID_154699830 | ||
| 0.154 | 0.055 | 0.154 | Nav1.2 sodium channel blocker | |||
| 0.108 | 0.01 | 0.108 | I kappa B kinase 2 inhibitor | |||
| 0.218 | 0.12 | 0.218 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.101 | 0.004 | 0.101 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.154 | 0.057 | 0.154 | Adenylate cyclase stimulant | |||
| 0.113 | 0.018 | 0.113 | Amidase inhibitor | |||
| 0.214 | 0.119 | 0.214 | Transcription factor STAT inhibitor | |||
| 0.107 | 0.015 | 0.107 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 CID_154699830 | ||
| 0.221 | 0.129 | 0.221 | 12-Lipoxygenase inhibitor | |||
| 0.116 | 0.025 | 0.116 | Somatostatin 1 agonist | |||
| 0.109 | 0.018 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.039 CID_154699830 | ||
| 0.135 | 0.044 | 0.135 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.266 | 0.176 | 0.266 | Transcription factor inhibitor | |||
| 0.12 | 0.03 | 0.12 | Toll-Like receptor 3 antagonist | |||
| 0.181 | 0.092 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.161 | 0.075 | 0.161 | Arachidonic acid antagonist | |||
| 0.103 | 0.018 | 0.103 | NMDA receptor agonist | |||
| 0.143 | 0.058 | 0.143 | Toll-Like receptor 2 antagonist | |||
| 0.261 | 0.177 | 0.261 | MAP kinase kinase 6 inhibitor | |||
| 0.153 | 0.07 | 0.153 | GABA C receptor rho-2 antagonist | |||
| 0.108 | 0.026 | 0.108 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.106 | 0.024 | 0.106 | Adenosine A3 receptor antagonist | 0.102 0.026 CID_154699830 | ||
| 0.137 | 0.056 | 0.137 | Anesthetic local | |||
| 0.113 | 0.032 | 0.113 | Phosphodiesterase I inhibitor | |||
| 0.104 | 0.025 | 0.104 | D-Ala-D-Ala ligase inhibitor | |||
| 0.191 | 0.111 | 0.31 | Peptidyltransferase inhibitor | 0.31 0.021 CID_154699830 | CID_154699830 | |
| 0.137 | 0.059 | 0.154 | Cyclooxygenase 3 inhibitor | 0.154 0.045 CID_154699830 | CID_154699830 | |
| 0.148 | 0.07 | 0.148 | Protein kinase stimulant | |||
| 0.142 | 0.065 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 CID_154699830 | ||
| 0.095 | 0.018 | 0.095 | Beta adrenoreceptor antagonist | |||
| 0.133 | 0.057 | 0.449 | Alkylator | 0.449 0.006 CID_154699830 | CID_154699830 | |
| 0.16 | 0.085 | 0.16 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.154 | 0.08 | 0.154 | Polo-like kinase-3 inhibitor | |||
| 0.116 | 0.042 | 0.116 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.083 | 0.01 | 0.083 | Mineralocorticoid receptor antagonist | |||
| 0.256 | 0.184 | 0.41 | Alpha-glucosidase inhibitor | 0.41 0.11 CID_154699830 | CID_154699830 | |
| 0.15 | 0.077 | 0.15 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.081 | 0.009 | 0.081 | Leukotriene A4 hydrolase inhibitor | |||
| 0.105 | 0.033 | 0.105 | Adrenaline agonist | |||
| 0.096 | 0.024 | 0.096 | MAP3K7 inhibitor | |||
| 0.084 | 0.015 | 0.084 | Cyclin D1 inhibitor | |||
| 0.081 | 0.013 | 0.081 | Aconitate hydratase inhibitor | |||
| 0.137 | 0.069 | 0.137 | Alkaline phosphatase inhibitor | |||
| 0.107 | 0.04 | 0.107 | Histamine N-methyltransferase inhibitor | |||
| 0.078 | 0.012 | 0.078 | Beta 2 adrenoreceptor antagonist | |||
| 0.093 | 0.027 | 0.093 | Cyclin E inhibitor | |||
| 0.106 | 0.041 | 0.106 | Phosphodiesterase IV inhibitor | |||
| 0.075 | 0.01 | 0.075 | Dihydroorotase inhibitor | |||
| 0.097 | 0.032 | 0.097 | Glutamate decarboxylase inhibitor | |||
| 0.13 | 0.066 | 0.13 | Vanilloid 1 agonist | |||
| 0.096 | 0.033 | 0.096 | Glutamate dehydrogenase inhibitor | 0.076 0.049 CID_154699830 | ||
| 0.091 | 0.028 | 0.091 | I kappa B kinase 1 inhibitor | |||
| 0.208 | 0.145 | 0.208 | Insulysin inhibitor | |||
| 0.151 | 0.088 | 0.151 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.083 | 0.019 | 0.083 | Acetyl-CoA transferase inhibitor | |||
| 0.084 | 0.021 | 0.084 | Beta 3 adrenoreceptor antagonist | |||
| 0.113 | 0.05 | 0.113 | Bronchodilator | |||
| 0.168 | 0.106 | 0.168 | Growth factor agonist | |||
| 0.083 | 0.023 | 0.123 | Purinergic P2X1 antagonist | 0.123 0.011 CID_154699830 | CID_154699830 | |
| 0.153 | 0.093 | 0.153 | Neurotensin receptor agonist | |||
| 0.175 | 0.116 | 0.352 | Cyclic AMP phosphodiesterase inhibitor | 0.352 0.025 CID_154699830 | CID_154699830 | |
| 0.12 | 0.061 | 0.12 | Monophenol monooxygenase inhibitor | |||
| 0.107 | 0.048 | 0.107 | MAP kinase kinase 1 inhibitor | |||
| 0.073 | 0.015 | 0.073 | Factor VIIa inhibitor | |||
| 0.078 | 0.019 | 0.078 | Beta 1 adrenoreceptor antagonist | |||
| 0.073 | 0.015 | 0.073 | Beta 2 adrenoreceptor agonist | |||
| 0.138 | 0.08 | 0.138 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.101 | 0.043 | 0.142 | NADH dehydrogenase inhibitor | 0.142 0.02 CID_154699830 | CID_154699830 | |
| 0.13 | 0.072 | 0.13 | Interleukin 4 antagonist | 0.126 0.077 CID_154699830 | ||
| 0.124 | 0.067 | 0.124 | Aldehyde dehydrogenase inhibitor | |||
| 0.119 | 0.062 | 0.119 | Interleukin 8 antagonist | |||
| 0.206 | 0.149 | 0.206 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.1 | 0.045 | 0.1 | Aminoacyl-tRNA synthetase inhibitor | 0.089 0.06 CID_154699830 | ||
| 0.097 | 0.043 | 0.097 | TIE antagonist | |||
| 0.111 | 0.057 | 0.145 | Expectorant | 0.145 0.037 CID_154699830 | CID_154699830 | |
| 0.09 | 0.036 | 0.09 | GABA aminotransferase inhibitor | |||
| 0.067 | 0.013 | 0.067 | Immunoglobulin Fc receptor antagonist | |||
| 0.072 | 0.018 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.06 | 0.007 | 0.06 | Cyclin E2 inhibitor | |||
| 0.104 | 0.052 | 0.104 | Electrolyte absorption antagonist | |||
| 0.095 | 0.043 | 0.095 | TIE-2 antagonist | |||
| 0.106 | 0.055 | 0.106 | GABA C receptor rho-1 antagonist | |||
| 0.182 | 0.132 | 0.182 | Calpain inhibitor | |||
| 0.142 | 0.092 | 0.142 | CF transmembrane conductance regulator agonist | |||
| 0.115 | 0.066 | 0.115 | Microtubule formation inhibitor | 0.1 0.091 CID_154699830 | ||
| 0.103 | 0.054 | 0.103 | Glutamate (mGluR7) agonist | |||
| 0.101 | 0.053 | 0.101 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.093 0.061 CID_154699830 | ||
| 0.092 | 0.045 | 0.092 | Glutathione S-transferase inhibitor | |||
| 0.18 | 0.133 | 0.457 | Immunostimulant | 0.457 0.035 CID_154699830 | CID_154699830 | |
| 0.136 | 0.091 | 0.136 | Heat shock protein 70 antagonist | |||
| 0.081 | 0.036 | 0.081 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.079 | 0.035 | 0.079 | Acetylcholine M5 receptor agonist | |||
| 0.063 | 0.019 | 0.063 | CXC chemokine 1 receptor antagonist | |||
| 0.063 | 0.019 | 0.271 | Heparanase inhibitor | 0.271 0.002 CID_154699830 | CID_154699830 | |
| 0.09 | 0.046 | 0.09 | Carbonic anhydrase VI inhibitor | |||
| 0.088 | 0.045 | 0.088 | Estrogen-related receptor beta agonist | |||
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | |||
| 0.057 | 0.014 | 0.057 | Kinesin-like protein 1 inhibitor | |||
| 0.057 | 0.014 | 0.057 | Kinesin antagonist | |||
| 0.133 | 0.091 | 0.133 | Hemostatic | |||
| 0.101 | 0.06 | 0.101 | Carbonic anhydrase III inhibitor | |||
| 0.074 | 0.033 | 0.074 | Glutamate (mGluR6) antagonist | |||
| 0.104 | 0.063 | 0.104 | GABA C receptor agonist | |||
| 0.086 | 0.046 | 0.105 | Carbonic anhydrase XIII inhibitor | 0.105 0.035 CID_154699830 | CID_154699830 | |
| 0.053 | 0.013 | 0.053 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.107 | 0.067 | 0.107 | GABA C receptor antagonist | |||
| 0.154 | 0.115 | 0.154 | I kappa B kinase epsilon inhibitor | |||
| 0.06 | 0.02 | 0.06 | Aldosterone antagonist | |||
| 0.068 | 0.028 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.088 | 0.049 | 0.088 | Neuropeptide Y antagonist | |||
| 0.059 | 0.02 | 0.104 | Purinergic P2Y antagonist | 0.104 0.009 CID_154699830 | CID_154699830 | |
| 0.053 | 0.015 | 0.053 | Dihydropteroate synthase inhibitor | |||
| 0.08 | 0.042 | 0.08 | Phosphodiesterase VI inhibitor | |||
| 0.176 | 0.139 | 0.348 | Hypoglycemic | 0.348 0.038 CID_154699830 | CID_154699830 | |
| 0.101 | 0.064 | 0.101 | Check point kinase 2 inhibitor | |||
| 0.093 | 0.056 | 0.093 | Glutamate release inhibitor | |||
| 0.158 | 0.121 | 0.158 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.15 | 0.115 | 0.15 | Pyruvate kinase inhibitor | |||
| 0.045 | 0.009 | 0.045 | Cyclophilin A inhibitor | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate oxidase inhibitor | |||
| 0.044 | 0.009 | 0.044 | Epoxide hydrolase 1 inhibitor | |||
| 0.083 | 0.047 | 0.083 | Fibroblast growth factor 3 antagonist | |||
| 0.078 | 0.045 | 0.078 | Protein kinase B beta inhibitor | |||
| 0.082 | 0.049 | 0.082 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | |||
| 0.046 | 0.014 | 0.046 | Delayed rectifier potassium channel blocker | |||
| 0.05 | 0.018 | 0.05 | Beta adrenoreceptor agonist | |||
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | |||
| 0.072 | 0.041 | 0.072 | Carbonic anhydrase V inhibitor | |||
| 0.042 | 0.011 | 0.042 | Uridine phosphorylase inhibitor | 0.027 0.021 CID_154699830 | ||
| 0.124 | 0.094 | 0.124 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.059 | 0.029 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_154699830 | CID_154699830 | |
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.062 | 0.033 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 CID_154699830 | ||
| 0.046 | 0.017 | 0.046 | Diamine oxidase inhibitor | |||
| 0.061 | 0.032 | 0.061 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.075 | 0.047 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.09 | 0.063 | 0.09 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.12 | 0.092 | 0.12 | Protein kinase C nu inhibitor | |||
| 0.046 | 0.019 | 0.046 | Vascular adhesion protein 1 inhibitor | |||
| 0.071 | 0.045 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.071 | 0.045 | 0.071 | Carbonic anhydrase VA inhibitor | |||
| 0.04 | 0.014 | 0.04 | Melatonin receptor 1A agonist | |||
| 0.034 | 0.01 | 0.034 | Calcium-sensing receptor agonist | |||
| 0.058 | 0.034 | 0.058 | Leukotriene C antagonist | |||
| 0.115 | 0.091 | 0.115 | Tyrosine-protein kinase receptor antagonist | |||
| 0.051 | 0.028 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.016 CID_154699830 | CID_154699830 | |
| 0.151 | 0.127 | 0.151 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.098 | 0.074 | 0.098 | Factor V inhibitor | |||
| 0.045 | 0.022 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.165 | 0.142 | 0.165 | ErbB-1 antagonist | |||
| 0.09 | 0.068 | 0.09 | Potassium channel (Voltage-sensitive) activator | |||
| 0.03 | 0.009 | 0.03 | Complement factor 1s inhibitor | |||
| 0.029 | 0.009 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.09 | 0.071 | 0.09 | Xanthine oxidase inhibitor | |||
| 0.028 | 0.009 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.09 | 0.071 | 0.09 | Creatine kinase inhibitor | |||
| 0.112 | 0.093 | 0.112 | NADPH oxidase inhibitor | |||
| 0.09 | 0.072 | 0.09 | Sphingomyelinase inhibitor | |||
| 0.119 | 0.101 | 0.119 | Cytidine deaminase inhibitor | |||
| 0.045 | 0.027 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.118 | 0.102 | 0.118 | Cell wall synthesis inhibitor | |||
| 0.102 | 0.086 | 0.102 | TRKA antagonist | |||
| 0.04 | 0.025 | 0.04 | MAP3K5 inhibitor | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.049 | 0.034 | 0.049 | Adenosine A2b receptor antagonist | |||
| 0.055 | 0.041 | 0.055 | Kallikrein 1 inhibitor | |||
| 0.052 | 0.037 | 0.052 | Ornithine carbamoyltransferase inhibitor | |||
| 0.066 | 0.051 | 0.101 | Phosphofructokinase-1 inhibitor | 0.101 0.031 CID_154699830 | CID_154699830 | |
| 0.035 | 0.021 | 0.035 | Somatostatin 5 antagonist | |||
| 0.074 | 0.06 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.084 | 0.098 | Vascular endothelial growth factor antagonist | |||
| 0.029 | 0.015 | 0.029 | CXC chemokine 2 receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Glutamate (mGluR3) agonist | |||
| 0.091 | 0.077 | 0.091 | Anabolic | |||
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.038 | 0.026 | 0.038 | Potassium channel Kv1.1 blocker | |||
| 0.15 | 0.138 | 0.15 | Neurotrophic factor enhancer | |||
| 0.109 | 0.098 | 0.109 | DNA repair enzyme inhibitor | |||
| 0.056 | 0.045 | 0.056 | Biliverdin reductase inhibitor | 0.052 0.05 CID_154699830 | ||
| 0.197 | 0.187 | 0.197 | Beta lactamase inhibitor | |||
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.052 | 0.043 | 0.052 | Carbonic anhydrase VB inhibitor | |||
| 0.023 | 0.014 | 0.023 | Isoleucine-tRNA ligase inhibitor | |||
| 0.048 | 0.04 | 0.048 | Sodium/calcium exchanger inhibitor | |||
| 0.038 | 0.031 | 0.038 | Leukotriene C4 antagonist | |||
| 0.045 | 0.04 | 0.045 | Cyclin E1 inhibitor | |||
| 0.023 | 0.018 | 0.023 | Epoxide hydrolase 2 inhibitor | |||
| 0.131 | 0.128 | 0.192 | DNA methyltransferase I inhibitor | 0.192 0.073 CID_154699830 | CID_154699830 | |
| 0.021 | 0.017 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Acetyl-CoA carboxylase inhibitor | |||
| 0.159 | 0.155 | 0.351 | Antioxidant | 0.351 0.046 CID_154699830 | CID_154699830 | |
| 0.031 | 0.027 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.035 | 0.032 | 0.035 | Glutamate (mGluR8) agonist | |||
| 0.059 | 0.055 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.086 | 0.083 | 0.086 | Vascular endothelial growth factor 2 antagonist | |||
| 0.071 | 0.069 | 0.071 | Interferon agonist | |||
| 0.19 | 0.188 | 0.19 | Vasodilator, peripheral | |||
| 0.091 | 0.089 | 0.091 | Cystathionine beta-synthase inhibitor | |||
| 0.049 | 0.048 | 0.049 | Argininosuccinate synthase inhibitor | |||
| 0.084 | 0.083 | 0.084 | MAP kinase kinase kinase inhibitor | |||
| 0.07 | 0.069 | 0.07 | Platelet growth factor antagonist | |||
| 0.043 | 0.05 | 0.141 | Carbonic anhydrase I inhibitor | 0.141 0.011 CID_154699830 | CID_154699830 | |
| 0.022 | 0.029 | 0.061 | Sodium/glucose cotransporter inhibitor | 0.061 0.004 CID_154699830 | CID_154699830 | |
| 0.129 | 0.139 | 0.195 | DNA methylase inhibitor | 0.195 0.083 CID_154699830 | CID_154699830 | |
| 0.091 | 0.106 | 0.11 | Amylase inhibitor | 0.11 0.088 CID_154699830 | CID_154699830 | |
| 0.028 | 0.045 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 CID_154699830 | CID_154699830 | |
| 0.037 | 0.054 | 0.171 | Carbonic anhydrase XIV inhibitor | 0.171 0.005 CID_154699830 | CID_154699830 | |
| 0.044 | 0.063 | 0.189 | Carbonic anhydrase inhibitor | 0.189 0.011 CID_154699830 | CID_154699830 | |
| 0.01 | 0.029 | 0.018 | Adenosine A2 receptor agonist | 0.018 0.009 CID_154699830 | CID_154699830 | |
| 0.072 | 0.093 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 CID_154699830 | CID_154699830 | |
| 0.034 | 0.057 | 0.233 | Carbonic anhydrase IX inhibitor | 0.233 0.006 CID_154699830 | CID_154699830 | |
| 0.031 | 0.054 | 0.282 | Carbonic anhydrase XII inhibitor | 0.282 0.005 CID_154699830 | CID_154699830 | |
| 0.036 | 0.06 | 0.133 | Carbonic anhydrase II inhibitor | 0.133 0.012 CID_154699830 | CID_154699830 | |
| 0.044 | 0.068 | 0.139 | Glucosylceramidase inhibitor | 0.139 0.004 CID_154699830 | CID_154699830 | |
| 0.132 | 0.158 | 0.355 | Hypolipemic | 0.355 0.034 CID_154699830 | CID_154699830 | |
| 0.033 | 0.062 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 CID_154699830 | CID_154699830 | |
| 0.036 | 0.067 | 0.052 | Adenosine A1 receptor antagonist | 0.052 0.047 CID_154699830 | CID_154699830 | |
| 0.008 | 0.039 | 0.092 | Ileal bile acid transport inhibitor | 0.092 0.002 CID_154699830 | CID_154699830 | |
| 0.026 | 0.064 | 0.423 | Phosphorylase inhibitor | 0.423 0.003 CID_154699830 | CID_154699830 | |
| 0.015 | 0.055 | 0.052 | Sodium/glucose cotransporter 2 inhibitor | 0.052 0.006 CID_154699830 | CID_154699830 | |
| 0.172 | 0.216 | 0.253 | Antithrombotic | 0.253 0.124 CID_154699830 | CID_154699830 | |
| 0.028 | 0.073 | 0.068 | Mannosidase inhibitor | 0.068 0.012 CID_154699830 | CID_154699830 | |
| 0.075 | 0.122 | 0.15 | AMP-activated protein kinase stimulant | 0.15 0.028 CID_154699830 | CID_154699830 | |
| 0.047 | 0.095 | 0.07 | Neuraminidase (influenza) inhibitor | 0.07 0.035 CID_154699830 | CID_154699830 | |
| 0.013 | 0.063 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 CID_154699830 | CID_154699830 | |
| 0.179 | 0.23 | 0.282 | Interleukin 2 agonist | 0.282 0.087 CID_154699830 | CID_154699830 | |
| 0.075 | 0.127 | 0.284 | Beta glucuronidase inhibitor | 0.284 0.007 CID_154699830 | CID_154699830 | |
| 0.034 | 0.092 | 0.067 | Alpha-mannosidase inhibitor | 0.067 0.019 CID_154699830 | CID_154699830 | |
| 0.124 | 0.185 | 0.155 | Catenin beta inhibitor | 0.155 0.095 CID_154699830 | CID_154699830 | |
| 0.031 | 0.099 | 0.058 | Neuraminidase inhibitor | 0.058 0.046 CID_154699830 | CID_154699830 | |
| 0.1 | 0.175 | 0.284 | Platelet adhesion inhibitor | 0.284 0.039 CID_154699830 | CID_154699830 | |
| 0.061 | 0.148 | 0.087 | Lanosterol 14 alpha demethylase inhibitor | 0.087 0.077 CID_154699830 | CID_154699830 | |
| 0.194 | 0.284 | 0.685 | Cyclophilin D inhibitor | 0.685 0.016 CID_154699830 | CID_154699830 | |
| 0.173 | 0.264 | 0.46 | Antibacterial | 0.46 0.053 CID_154699830 | CID_154699830 | |
| 0.059 | 0.168 | 0.143 | DNA polymerase I inhibitor | 0.143 0.053 CID_154699830 | CID_154699830 | |
| 0.05 | 0.16 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.055 CID_154699830 | CID_154699830 | |
| 0.068 | 0.203 | 0.161 | Cell adhesion inhibitor | 0.161 0.04 CID_154699830 | CID_154699830 | |
| 0.026 | 0.181 | 0.078 | Factor IXa inhibitor | 0.078 0.017 CID_154699830 | CID_154699830 | |
| 0.048 | 0.236 | 0.263 | Lipid peroxidase inhibitor | 0.263 0.024 CID_154699830 | CID_154699830 | |
| 0.004 | 0.209 | 0.013 | Retinoic acid receptor gamma antagonist | 0.013 0.007 CID_154699830 | CID_154699830 | |
| 0.166 | 0.386 | 0.307 | Antiinflammatory | 0.307 0.208 CID_154699830 | CID_154699830 | |
| 0.005 | 0.228 | 0.019 | Retinoic acid receptor antagonist | 0.019 0.012 CID_154699830 | CID_154699830 | |
| 0.067 | 0.303 | 0.221 | Hepatoprotectant | 0.221 0.054 CID_154699830 | CID_154699830 | |
| 0.05 | 0.288 | 0.347 | Angiogenesis stimulant | 0.347 0.034 CID_154699830 | CID_154699830 | |
| 0.013 | 0.283 | 0.227 | Selectin antagonist | 0.227 0.009 CID_154699830 | CID_154699830 | |
| 0.033 | 0.324 | 0.055 | Lipocortins synthesis agonist | 0.055 0.048 CID_154699830 | CID_154699830 | |
| 0.078 | 0.382 | 0.367 | Immunosuppressant | 0.367 0.078 CID_154699830 | CID_154699830 | |
| 0.088 | 0.398 | 0.22 | Immunomodulator | 0.22 0.141 CID_154699830 | CID_154699830 | |
| 0.051 | 0.373 | 0.271 | Free radical scavenger | 0.271 0.06 CID_154699830 | CID_154699830 | |
| 0.031 | 0.355 | 0.156 | Thrombolytic | 0.156 0.077 CID_154699830 | CID_154699830 | |
| 0.005 | 0.39 | 0.083 | Antineoplastic antibiotic | 0.083 0.055 CID_154699830 | CID_154699830 | |
| 0.016 | 0.447 | 0.093 | Topoisomerase I inhibitor | 0.093 0.077 CID_154699830 | CID_154699830 | |
| 0.036 | 0.494 | 0.138 | Nitric oxide antagonist | 0.138 0.107 CID_154699830 | CID_154699830 | |
| 0.054 | 0.623 | 0.248 | Apoptosis agonist | 0.248 0.217 CID_154699830 | CID_154699830 | |
| 0.072 | 0.65 | 0.121 | CC chemokine 6 receptor antagonist | 0.121 0.109 CID_154699830 | CID_154699830 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |